[1] |
Siegel RL,Jakubowski CD,Fedewa SA,et al.Colorectal Cancer in the Young:Epidemiology,Prevention,Management[J]. Am Soc Clin Oncol Educ Book,2020,40:1-14.
|
[2] |
Federica P, Gutierrez-Bravo MF, Cabeza-Segura M, et al.Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine[J].Ann Oncol,2019,30(Suppl 5):v240-v241.
|
[3] |
Sachs N,Papaspyropoulos A,Zomer-Van Ommen DD,et al.Longterm expanding human airway organoids for disease modeling[J].EMBO J,2019,38(4): e100300.
|
[4] |
Xin X,Satya SP,Limei S,et al.Establishment and characterization of 3D cancer organoids as clinically relevant ex vivo drug screening tools for cancer translational research and drug discovery[J].Cancer Res,2019,79(13-Supplement):1925.
|
[5] |
Pinto D,Gregorieff A,Begthel H,et al.Canonical Wnt signals are essential for homeostasis of the intestinal epithelium[J]. Genes Dev,2003,17(14):1709-1713.
|
[6] |
Kuhnert F,Davis CR, Wang HT, et al.Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1[J]. Proc Natl Acad Sci U S A,2004,101(1):266-271.
|
[7] |
Haramis AP,Begthel H,Van Den Born M,et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine[J].Science,2004,303(5664):1684-1686.
|
[8] |
Hanyu H,Sugimoto S,Sato T.Visualization of Differentiated Cells in 3D and 2D Intestinal Organoid Cultures[J]. Methods Mol Biol,2023,2650:141-153.
|
[9] |
Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J].Nature,2009,459(7244):262-265.
|
[10] |
Fujii M, Matano M, Toshimitsu K, et al. Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition[J].Cell Stem Cell,2018,23(6):787-793,e786.
|
[11] |
Vlachogiannis G,Hedayat S,Vatsiou A,et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J].Science,2018,359(6378):920-926.
|
[12] |
Driehuis E, Van Hoeck A, Moore K, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening[J].Proc Natl Acad Sci U S A,2019,116(52):26580-26590.
|
[13] |
Weeber F,Ooft SN,Dijkstra KK,et al.Tumor Organoids as a Preclinical Cancer Model for Drug Discovery[J]. Cell Chem Biol,2017,24(9):1092-1100.
|
[14] |
Mohammadi S, Morell-Perez C, Wright CW, et al. Assessing donor-to-donor variability in human intestinal organoid cultures[J].Stem Cell Rep,2021,16(9):2364-2378.
|
[15] |
Zhang XS,Xie G,Ma H,et al. Highly reproducible and costeffective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly[J].Biofabrication,2023,15(4):10.1088/1758-5090/acee1021.
|
[16] |
Hernández D,Rooney LA,Daniszewski M,et al.Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer′s Disease[J].Stem Cell Rev Rep,2022,18(2):718-731.
|
[17] |
Phipson B,Er PX,Combes AN,et al. Evaluation of variability in human kidney organoids[J].Nat Methods,2019,16(1):79-87.
|
[18] |
Xu Q, Halle L, Hediyeh-Zadeh S, et al. An integrated transcriptomic cell atlas of human endoderm-derived organoids[J].Nat Genet,2025,57(5):1201-1212.
|
[19] |
中华医学会消化病学分会医工交叉协作组.中国经内镜消化系统常见恶性肿瘤组织取样及类器官培养专家共识(2024,成都)[J].中华消化内镜杂志,2024,41(5):337-350.
|
[20] |
曾云丽,王穗东,李怡然,等.1231 例结直肠癌类器官培养成功率的影响因素分析[J].中华胃肠外科杂志,2023,26(8):780-786.
|
[21] |
Ganesh K,Wu C,O′rourke KP,et al. A rectal cancer organoid platform to study individual responses to chemoradiation[J].Nat Med,2019,25(10):1607-1614.
|
[22] |
Yao Y,Xu X,Yang L,et al. Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer[J].Cell Stem Cell,2020,26(1):17-26,e16.
|
[23] |
Pleguezuelos-Manzano C,Puschhof J,Van Den Brink S,et al.Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells[J].Curr Protoc Immunol,2020,130(1):e106.
|
[24] |
Tsai YH,Czerwinski M,Wu A,et al. A Method for Cryogenic Preservation of Human Biopsy Specimens and Subsequent Organoid Culture[J]. Cell Mol Gastroenterol Hepatol,2018,6(2):218-222.e217.
|
[25] |
Sato T,Stange DE,Ferrante M,et al. Long-term expansion of epithelialorganoidsfromhumancolon,adenoma,adenocarcinoma, and Barrett′s epithelium[J]. Gastroenterology,2011,141(5):1762-1772.
|
[26] |
Jang KK,Kaczmarek ME,Dallari S,et al. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection[J].PLoS Biol,2022,20(3):e3001592.
|
[27] |
Dotti I,Mora-Buch R,Ferrer-Picón E,et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis[J].Gut,2017,66(12):2069-2079.
|
[28] |
Jung P,Sato T,Merlos-Suárez A,et al. Isolation and in vitro expansion of human colonic stem cells[J]. Nat Med,2011,17(10):1225-1227.
|
[29] |
Yang C,Xiao W,Wang R, et al. Tumor organoid model of colorectal cancer (Review)[J].Oncol Lett,2023,26(2):328.
|
[30] |
Yong Hun J,Donghee C,Kyungwon P,et al. Drug screening by uniform patient derived colorectal cancer hydro-organoids[J].Biomaterials,2021,276:121004.
|
[31] |
Yunuo M,Wei W,Jingwei Y,et al. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids[J]. Protein & Cell,2023,15(4):285-304.
|
[32] |
Yasmine A, Ruud V, Mayke D, et al. Miniaturizing patientderived organoid screening assays for predictive drug testing[J].Cancer Res,2024,84(6-Supplement):4247.
|
[33] |
Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice[J].Nat Rev Immunol,2020,20(11):651-668.
|
[34] |
Dekkers JF,Alieva M,Cleven A,et al. Uncovering the mode of action of engineered T cells in patient cancer organoids[J]. Nat Biotechnol,2023,41(1):60-69.
|
[35] |
Cattaneo CM,Dijkstra KK,Fanchi LF,et al. Tumor organoid-T-cell coculture systems[J].Nat Protoc,2020,15(1):15-39.
|
[36] |
Schnalzger TE,De Groot M H,Zhang C,et al.3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids[J]. EMBO J,2019,38(12):e100928.
|
[37] |
Teijeira A,Migueliz I,Garasa S,et al. Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers[J]. Theranostics,2022,12(3):1373-1387.
|